Clinical trial

Aliskiren Study of Safety and Efficacy in Senior Hypertensives

NCT01922141

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2015-05-01

PhasePHASE4

Study timeline

Study start (unknown)2015-05-01Date precision: month

Registry last updated2015-04-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

AliskirenDRUG · verified · RxNorm: aliskiren

AmlodipineDRUG · verified · RxNorm: amlodipine

RamiprilDRUG · verified · RxNorm: ramipril

HydrochlorothiazideDRUG · verified · RxNorm: hydrochlorothiazide

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01922141 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.